PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1

p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2009-02, Vol.379 (3), p.721-725
Hauptverfasser: Rankin, Sherri L., Guy, Clifford S., Mearow, Karen M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 725
container_issue 3
container_start_page 721
container_title Biochemical and biophysical research communications
container_volume 379
creator Rankin, Sherri L.
Guy, Clifford S.
Mearow, Karen M.
description p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.
doi_str_mv 10.1016/j.bbrc.2008.12.075
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21255879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X08025011</els_id><sourcerecordid>20254807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi1ERbeFF-CAIiH1lnTGiZ1E4lK1pSBVC4JF4mY5k0nxajdO7Wxh356EXYkbzMVz-OYfjT8hXiNkCKgv11nTBMokQJWhzKBUz8QCoYZUIhTPxQIAdCpr_H4qzmJcAyAWun4hTrGeOsiLhVh-Xt0uk9b_7AM_7DZ25JgMpVquviT8awgco_N90uyTlimwja5_SG6WV2nj-nbuLY3uyY37xHfJ1wFfipPObiK_Or7n4tv729X1h_T-093H66v7lArMxxQt6U4ydDkQYdHZulEEVkPeNJQXdTUVWl0TKKuUolKVGnOsSyZmhDI_F28PuT6OzkRyI9MP8n3PNBqJUqmqrCfq4kANwT_uOI5m6yLxZmN79rtotK40ViX-F5QgVVH92SsPIAUfY-DODMFtbdgbBDNLMWszSzGzFIPSTFKmoTfH9F2z5fbvyNHCBLw7ADx92ZPjMF_EPXHrwnxQ692_8n8D0rabGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20254807</pqid></control><display><type>article</type><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</creator><creatorcontrib>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</creatorcontrib><description>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2008.12.075</identifier><identifier>PMID: 19114034</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Animals ; Cell Line, Tumor ; Cell Nucleus - enzymology ; CHROMATIN ; Chromatin immunoprecipitation ; DNA ; DNA - metabolism ; Down-Regulation ; ELECTROPHORESIS ; Electrophoretic Mobility Shift Assay ; Gene Expression Regulation ; GENE REGULATION ; Laminin ; Laminin - metabolism ; Laminin - pharmacology ; MUTANTS ; Mutation ; NERVOUS SYSTEM ; Neurons - drug effects ; Neurons - enzymology ; Nuclear localization ; p75NTR ; PROMOTERS ; PTEN ; PTEN Phosphohydrolase - genetics ; PTEN Phosphohydrolase - metabolism ; Rats ; Receptor, Nerve Growth Factor - genetics ; RECEPTORS ; Sp1 ; Sp1 Transcription Factor - metabolism ; STIMULATION ; TRANSCRIPTION ; TRANSCRIPTION FACTORS ; Transcription, Genetic - drug effects</subject><ispartof>Biochemical and biophysical research communications, 2009-02, Vol.379 (3), p.721-725</ispartof><rights>2008 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</citedby><cites>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2008.12.075$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19114034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21255879$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Rankin, Sherri L.</creatorcontrib><creatorcontrib>Guy, Clifford S.</creatorcontrib><creatorcontrib>Mearow, Karen M.</creatorcontrib><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Animals</subject><subject>Cell Line, Tumor</subject><subject>Cell Nucleus - enzymology</subject><subject>CHROMATIN</subject><subject>Chromatin immunoprecipitation</subject><subject>DNA</subject><subject>DNA - metabolism</subject><subject>Down-Regulation</subject><subject>ELECTROPHORESIS</subject><subject>Electrophoretic Mobility Shift Assay</subject><subject>Gene Expression Regulation</subject><subject>GENE REGULATION</subject><subject>Laminin</subject><subject>Laminin - metabolism</subject><subject>Laminin - pharmacology</subject><subject>MUTANTS</subject><subject>Mutation</subject><subject>NERVOUS SYSTEM</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Nuclear localization</subject><subject>p75NTR</subject><subject>PROMOTERS</subject><subject>PTEN</subject><subject>PTEN Phosphohydrolase - genetics</subject><subject>PTEN Phosphohydrolase - metabolism</subject><subject>Rats</subject><subject>Receptor, Nerve Growth Factor - genetics</subject><subject>RECEPTORS</subject><subject>Sp1</subject><subject>Sp1 Transcription Factor - metabolism</subject><subject>STIMULATION</subject><subject>TRANSCRIPTION</subject><subject>TRANSCRIPTION FACTORS</subject><subject>Transcription, Genetic - drug effects</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi1ERbeFF-CAIiH1lnTGiZ1E4lK1pSBVC4JF4mY5k0nxajdO7Wxh356EXYkbzMVz-OYfjT8hXiNkCKgv11nTBMokQJWhzKBUz8QCoYZUIhTPxQIAdCpr_H4qzmJcAyAWun4hTrGeOsiLhVh-Xt0uk9b_7AM_7DZ25JgMpVquviT8awgco_N90uyTlimwja5_SG6WV2nj-nbuLY3uyY37xHfJ1wFfipPObiK_Or7n4tv729X1h_T-093H66v7lArMxxQt6U4ydDkQYdHZulEEVkPeNJQXdTUVWl0TKKuUolKVGnOsSyZmhDI_F28PuT6OzkRyI9MP8n3PNBqJUqmqrCfq4kANwT_uOI5m6yLxZmN79rtotK40ViX-F5QgVVH92SsPIAUfY-DODMFtbdgbBDNLMWszSzGzFIPSTFKmoTfH9F2z5fbvyNHCBLw7ADx92ZPjMF_EPXHrwnxQ692_8n8D0rabGQ</recordid><startdate>20090213</startdate><enddate>20090213</enddate><creator>Rankin, Sherri L.</creator><creator>Guy, Clifford S.</creator><creator>Mearow, Karen M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20090213</creationdate><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><author>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Animals</topic><topic>Cell Line, Tumor</topic><topic>Cell Nucleus - enzymology</topic><topic>CHROMATIN</topic><topic>Chromatin immunoprecipitation</topic><topic>DNA</topic><topic>DNA - metabolism</topic><topic>Down-Regulation</topic><topic>ELECTROPHORESIS</topic><topic>Electrophoretic Mobility Shift Assay</topic><topic>Gene Expression Regulation</topic><topic>GENE REGULATION</topic><topic>Laminin</topic><topic>Laminin - metabolism</topic><topic>Laminin - pharmacology</topic><topic>MUTANTS</topic><topic>Mutation</topic><topic>NERVOUS SYSTEM</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Nuclear localization</topic><topic>p75NTR</topic><topic>PROMOTERS</topic><topic>PTEN</topic><topic>PTEN Phosphohydrolase - genetics</topic><topic>PTEN Phosphohydrolase - metabolism</topic><topic>Rats</topic><topic>Receptor, Nerve Growth Factor - genetics</topic><topic>RECEPTORS</topic><topic>Sp1</topic><topic>Sp1 Transcription Factor - metabolism</topic><topic>STIMULATION</topic><topic>TRANSCRIPTION</topic><topic>TRANSCRIPTION FACTORS</topic><topic>Transcription, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rankin, Sherri L.</creatorcontrib><creatorcontrib>Guy, Clifford S.</creatorcontrib><creatorcontrib>Mearow, Karen M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rankin, Sherri L.</au><au>Guy, Clifford S.</au><au>Mearow, Karen M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2009-02-13</date><risdate>2009</risdate><volume>379</volume><issue>3</issue><spage>721</spage><epage>725</epage><pages>721-725</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19114034</pmid><doi>10.1016/j.bbrc.2008.12.075</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2009-02, Vol.379 (3), p.721-725
issn 0006-291X
1090-2104
language eng
recordid cdi_osti_scitechconnect_21255879
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 60 APPLIED LIFE SCIENCES
Animals
Cell Line, Tumor
Cell Nucleus - enzymology
CHROMATIN
Chromatin immunoprecipitation
DNA
DNA - metabolism
Down-Regulation
ELECTROPHORESIS
Electrophoretic Mobility Shift Assay
Gene Expression Regulation
GENE REGULATION
Laminin
Laminin - metabolism
Laminin - pharmacology
MUTANTS
Mutation
NERVOUS SYSTEM
Neurons - drug effects
Neurons - enzymology
Nuclear localization
p75NTR
PROMOTERS
PTEN
PTEN Phosphohydrolase - genetics
PTEN Phosphohydrolase - metabolism
Rats
Receptor, Nerve Growth Factor - genetics
RECEPTORS
Sp1
Sp1 Transcription Factor - metabolism
STIMULATION
TRANSCRIPTION
TRANSCRIPTION FACTORS
Transcription, Genetic - drug effects
title PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T03%3A49%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PTEN%20downregulates%20p75NTR%20expression%20by%20decreasing%20DNA-binding%20activity%20of%20Sp1&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Rankin,%20Sherri%20L.&rft.date=2009-02-13&rft.volume=379&rft.issue=3&rft.spage=721&rft.epage=725&rft.pages=721-725&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2008.12.075&rft_dat=%3Cproquest_osti_%3E20254807%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20254807&rft_id=info:pmid/19114034&rft_els_id=S0006291X08025011&rfr_iscdi=true